DaTSCAN
Drug
GE HEALTHCARE
Total Payments
$129,130
Transactions
3
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $54,810 | 1 | 0 |
| 2021 | $74,320 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $129,130 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Dementia with Lewy Body Consortium | GE Healthcare | $73,320 | 0 |
| DEMENTIA WITH LEWIS BODY CONSORTIUM | GE HEALTHCARE | $54,810 | 0 |
| DATSCAN IMAGING IN AGING WITH NEURODEGENERATIVE DISEASES | GE HEALTHCARE | $1,000 | 0 |
Top Doctors Receiving Payments for DaTSCAN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Rochester, MN | $129,130 | 3 |
Ad
Manufacturing Companies
- GE Healthcare $73,320
- GE HEALTHCARE $55,810
Product Information
- Type Drug
- Total Payments $129,130
- Total Doctors 0
- Transactions 3
About DaTSCAN
DaTSCAN is a drug associated with $129,130 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is GE HEALTHCARE.
Payment data is available from 2021 to 2022. In 2022, $54,810 was paid across 1 transactions to 0 doctors.
The most common payment nature for DaTSCAN is "Unspecified" ($129,130, 100.0% of total).
DaTSCAN is associated with 3 research studies, including "Dementia with Lewy Body Consortium" ($73,320).